Johnson & Johnson (JNJ) NYSE
225.77
-1.735(-0.76%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
225.77
-1.735(-0.76%)
Currency In USD
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States of America (the)
Phone
732 524 0400
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
138100
First IPO Date
January 02, 1943
| Name | Title | Pay | Year Born |
| Joaquin Duato | CEO & Chairman | 5.9M | 1963 |
| Joseph J. Wolk | Executive VP & CFO | 3.08M | 1967 |
| John C. Reed | Executive Vice President of Innovative Medicine, R&D | 3.11M | 1958 |
| Jennifer L. Taubert | Executive VP & Worldwide Chairman of Innovative Medicine | 3.16M | 1964 |
| Timothy Schmid | Executive VP & Worldwide Chairman of MedTech | 6.34M | 1970 |
| Darren Snellgrove | Vice President of Investor Relations | 0 | N/A |
| Dirk Brinckman | Chief Compliance Officer | 0 | N/A |
| James Swanson | Executive VP & Chief Information Officer | 0 | 1966 |
| Robert J. Decker Jr. | Controller & Chief Accounting Officer | 0 | 1973 |
| Elizabeth Forminard | Executive VP & Chief Legal Officer | 0 | 1971 |
| Kristen Blair Mulholland | Executive VP & Chief Human Resources Officer | 0 | N/A |
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.